Inhibition of lymphocyte transformation by a placental glycoprotein.

Immunological studies of the human placenta. Characterization of immunoglobulins on trophoblastic basement membranes. J Clin Invest (1974) 1.36

Lymphocyte reactivity in pregnant women and newborn infants. Br Med J (1975) 1.31

[Immunochemical investigations on the protein of the "pregnancy zone". X. Demonstration of immunosuppressive activities of the pregnancy-associated alpha2-glycoprotein (pregnancy zone protein) by means of the macrophage electrophoretic mobility test (author's transl)]. Arch Gynakol (1975) 0.90

Immunosuppresive effect of a human hepatic glycoferroprotein, alpha2H globulin. A study on the transformation of normal human lymphocytes. Immunology (1975) 0.80

In vitro modulation of lymphocyte responses to phytohaemagglutinin by plasma in mother and baby at the time of birth. Increased lymphocyte responses in babies of mothers with lepromatous leprosy. Clin Exp Immunol (1978) 0.77

Human placental heteroantigens demonstrable by immunodiffusion. Br J Exp Pathol (1974) 0.75

Placenta, transcortin, and localized immune response. J Clin Invest (1976) 0.75

The effect of race on access and outcome in transplantation. N Engl J Med (1991) 2.98

In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci U S A (1993) 2.39

Hepatitis B infection. A point-prevalence study in 15 US hemodialysis centers. JAMA (1974) 1.92

Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade. N Engl J Med (1979) 1.83

Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. Crit Care Med (1996) 1.82

Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis (1998) 1.77

Viral syndromes and renal homograft rejection. Ann Surg (1972) 1.74

Hepatitis B "immune" globulin: effectiveness in prevention of dialysis-associated hepatitis. N Engl J Med (1975) 1.66

Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure. Am J Kidney Dis (1997) 1.48

Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction. J Exp Med (1991) 1.40

Collagen as a biomaterial. Annu Rev Biophys Bioeng (1974) 1.40

Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation. A potential strategy to avoid antibody induction protocols. Transplantation (1993) 1.39

Milk safety. Science (1994) 1.38

Ocular complications in renal transplant recipients. Am J Med (1973) 1.38

Hydroxyl radical scavengers inhibit lymphocyte mitogenesis. Proc Natl Acad Sci U S A (1982) 1.36

Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood. Infect Immun (1995) 1.33

Sounding board: Effective primary care by the subspecialty center. N Engl J Med (1975) 1.32

Alpha-2-globulins in renal graft rejection. Effects of in vitro lymphocyte function. Transplantation (1969) 1.29

Cytomegalovirus infections with viremia following renal transplantation. Arch Intern Med (1971) 1.24

Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. Crit Care Med (2001) 1.22

Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate. J Immunol (1984) 1.20

Ototoxicity induced by furosemide. N Engl J Med (1970) 1.19

Generation of a lymphocyte growth factor by treatment of human cells with neuraminidase and galactose oxidase. J Exp Med (1980) 1.18

Selective suppression by adherent cells, prostaglandin, and cyclic AMP analogues of blastogenesis induced by different mitogens. J Immunol (1979) 1.14

Transvenous atrial pacing in the treatment of refractory ventricular irritability. Ann Intern Med (1967) 1.12

The nitroblue-tetrazolium test. Usefulness in detecting bacterial infections in uraemic and immunosuppressed renal transplant patients. Lancet (1972) 1.11

Hypercalcemia after renal transplantation. Long-term follow-up data. N Engl J Med (1973) 1.09

Progressive state selection of cells in low serum promotes high density growth and neoplastic transformation in NIH 3T3 cells. Cancer Res (1990) 1.08

Hydroxyl radical scavengers inhibit human natural killer cell activity. Nature (1984) 1.08

Effect of polar organic compounds on leukemic cells. Butyrate-induced partial remission of acute myelogenous leukemia in a child. Cancer (1983) 1.08

Dermatologic evaluation of pruritus in patients on hemodialysis. N Y State J Med (1973) 1.08

Hypocalcemia following bilateral nephrectomy. Urology (1973) 1.07

Plasma prorenin and renin in anephric patients. Circ Res (1977) 1.04

Direct autoradiographic visualisation in SDS-gels of lectin-binding components of the human erythrocyte membrane. FEBS Lett (1975) 1.02

Hypercalcemia after renal transplantation. Am J Med (1970) 0.98

HLA-A28 and steroid-induced diabetes in renal transplant patients. JAMA (1980) 0.98

Association between Streptococcus faecalis urinary infections and graft rejection in kidney transplantation. Lancet (1978) 0.97

Cytomegalovirus infection after renal transplantation. Report of a case with viremia and atypical lymphocytosis. JAMA (1969) 0.96

Selective effects of TPA and IL-1 on protein phosphorylation in murine thymocytes. Cell Immunol (1985) 0.96

Transglutaminase activity in human lymphocytes: early activation by phytomitogens. Proc Natl Acad Sci U S A (1978) 0.96

Impact of renal donation. Long-term clinical and biochemical follow-up of living donors in a single center. Am J Med (1985) 0.94

Stimulation of human peripheral blood lymphocytes by periodate, galactose oxidase, soybean agglutinin, and peanut agglutinin: differential effects of adherent cells. J Immunol (1977) 0.94

Renal allograft fracture: clinicopathological study of 21 cases. Ann Surg (1977) 0.94

Lymphocyte commitment to DNA replication induced by concanavalin A. Exp Cell Res (1978) 0.93

Regulation of new DNA synthesis in mammalian cells by cyclosporine. Demonstration of a transforming growth factor beta-dependent mechanism of inhibition of cell growth. Transplantation (1994) 0.93

Characterization of 'e' antigen associated with hepatitis B. Clin Exp Immunol (1979) 0.93

Biosynthesis of gamma globulin: studies in a cell-free system. Science (1966) 0.93

Reduction of ferricytochrome C may underestimate superoxide production by monocytes. J Immunol Methods (1987) 0.92

Hepatitis B immune globulin: final report of a controlled, multicenter trial of efficacy in prevention of dialysis-associated hepatitis. J Infect Dis (1978) 0.92

In vitro synthesis of brain protein. Proc Natl Acad Sci U S A (1965) 0.91

Depression of lymphocyte transformation by drugs in vitro. Effects of a new immunosuppressant, Cinanserin. Transplantation (1969) 0.91

Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis (1992) 0.91

Resumption of female reproductive function following renal transplantation. JAMA (1971) 0.91

Living renal donor. Nephrectomy: evaluation of 135 cases. J Urol (1973) 0.91

Lupus erythematosus-like disease due to hydrazine. Am J Med (1983) 0.90

Activation of human T cells with the physiological regulator of protein kinase C. Cell Immunol (1988) 0.90